XML 78 R61.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Mar. 29, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Total Stock-Based Compensation Cost and Associated Income Tax Benefits
Total stock-based compensation cost and the associated income tax benefits recognized in the Consolidated Statements of Operations, on a continuing operations basis, are as follows:
Year Ended March
(In thousands)202520242023
Stock-based compensation cost$73,247 $57,829 $40,040 
Income tax benefits16,299 12,849 9,072 
Schedule of Assumption Used and Resulting Weighted Average Fair Value of Stock Option Granted
The grant date fair value of each option award was calculated using a lattice option-pricing valuation model, which incorporated a range of assumptions for inputs as follows:
Year Ended March
202520242023
Expected volatility
37% to 53%
33% to 54%
30% to 46%
Weighted average expected volatility47%42%39%
Expected term (in years)
5.5 to 7.3
5.9 to 7.8
6.0 to 7.8
Weighted average dividend yield2.2%3.7%2.9%
Risk-free interest rate
3.80% to 5.43%
3.80% to 5.50%
1.53% to 4.89%
Weighted average fair value at date of grant$5.31$5.74$13.46
Schedule of Stock Option Activity
Stock option activity for the year ended March 2025 is summarized as follows:
Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Term (Years)Aggregate Intrinsic Value
(In thousands)
Outstanding, March 202413,034,540 $45.04 
Granted6,580,674 13.30 
Exercised(174,882)17.86 
Forfeited/cancelled(2,359,894)47.14 
Outstanding, March 202517,080,438 $32.80 7.2$17,174 
Exercisable, March 20257,584,683 $53.51 5.3$102 
Schedule of RSU Activity
RSU and stock unit activity for the year ended March 2025 is summarized as follows:
 Performance-basedNonperformance-based
 
Number Outstanding (a)
Weighted Average
Grant Date
Fair Value		Number OutstandingWeighted Average
Grant Date
Fair Value
Outstanding, March 20241,132,322 $40.14 4,305,296 $24.68 
Granted1,544,680 16.61 3,684,775 17.13 
Issued as Common Stock— — (980,773)37.79 
Forfeited/cancelled(275,230)86.13 (997,448)19.91 
Outstanding, March 20252,401,772 $19.60 6,011,850 $18.70 
Vested, March 2025840,579 $23.98 329,772 $20.58 
(a)Reflects activity at target level of awards and has not been adjusted for performance and market conditions, except for awards issued during the period.
Schedule of Restricted Stock Activity
Restricted stock activity for the year ended March 2025 is summarized below:
Nonvested Shares OutstandingWeighted Average Grant Date Fair Value
Nonvested shares, March 2024263,083 $65.90 
Granted— — 
Dividend equivalents737 14.99 
Vested(214,363)77.35 
Forfeited(37,844)47.22 
Nonvested shares, March 202511,613 $71.43